- Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology
-
Bogani G, Leone Roberti Maggiore U, Raspagliesi F
- KMID: 2417471
- J Gynecol Oncol.
- 2018 Sep;29(5):e84.
- doi: 10.3802/jgo.2018.29.e84
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Current landscape and future perspective of sentinel node mapping in endometrial cancer
-
Bogani G, Raspagliesi F, Leone Roberti Maggiore U, Mariani A
- KMID: 2431239
- J Gynecol Oncol.
- 2018 Nov;29(6):e94.
- doi: 10.3802/jgo.2018.29.e94
Endometrial cancer (EC) represents the most common gynecological neoplasm in developed countries. Surgery is the mainstay of treatment for EC. Although EC is characterized by a high prevalence several features... -
- CITED
-
- Close
- SHARE
-
- Close
- Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery
-
Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Leone C, Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2457139
- J Gynecol Oncol.
- 2019 Mar;30(2):e27.
- doi: 10.3802/jgo.2019.30.e27
OBJECTIVES: Nerve-sparing radical hysterectomy has been implemented in order to reduce pelvic floor dysfunctions in women undergoing radical surgery for cervical cancer. Here, we aimed to investigate if the adoption... -
- CITED
-
- Close
- SHARE
-
- Close
- Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
-
Ditto A, Bogani G, Leone Roberti Maggiore U, Martinelli F, Chiappa V, Lopez C, Perotto S, Lorusso D, Raspagliesi F
- KMID: 2409942
- J Gynecol Oncol.
- 2018 May;29(3):e41.
- doi: 10.3802/jgo.2018.29.e41
OBJECTIVE: Nerve-sparing radical hysterectomy (NSRH) was introduced with the aim to reduce pelvic dysfunctions related to conventional radical hysterectomy (RH). Here, we sought to assess the effectiveness and safety of... -
- CITED
-
- Close
- SHARE
-
- Close
- A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
-
Bogani G, Tagliabue , Signorelli M, Ditto A, Martinelli F, Chiappa V, Mosca L, Sabatucci , Leone Roberti Maggiore U, Lorusso D, Raspagliesi F
- KMID: 2409941
- J Gynecol Oncol.
- 2018 May;29(3):e40.
- doi: 10.3802/jgo.2018.29.e40
OBJECTIVE: To test the applicability of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Memorial Sloan Kettering (MSK) criteria in predicting complete cytoreduction (CC) in patients undergoing secondary cytoreductive surgery (SCS) for... -
- CITED
-
- Close
- SHARE
-
- Close
- Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
-
Bogani G, Rossetti D, Ditto A, Martinelli F, Chiappa V, Mosca L, Leone Roberti Maggiore U, Ferla S, Lorusso D, Raspagliesi F
- KMID: 2417462
- J Gynecol Oncol.
- 2018 Sep;29(5):e66.
- doi: 10.3802/jgo.2018.29.e66
OBJECTIVE: Accumulating evidence support that complete cytoreduction (CC) at the time of secondary cytoreductive surgery (SCS) improves survival in patients affected by recurrent ovarian cancer (ROC). Here, we aimed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
-
Leone Roberti Maggiore U, Martinelli F, Dondi G, Bogani G, Chiappa V, Evangelista MT, Liberale V, Ditto A, Ferrero S, Raspagliesi F
- KMID: 2450236
- J Gynecol Oncol.
- 2019 Jul;30(4):e57.
- doi: 10.3802/jgo.2019.30.e57
OBJECTIVE: To investigate the efficacy of levonorgestrel-releasing intra-uterine system (LNG-IUS) treatment in patients affected by atypical complex hyperplasia/endometrial cancer (ACH/EC) wishing to preserve their fertility and to present fertility outcomes... -
- CITED
-
- Close
- SHARE
-
- Close
- The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
-
Bogani G, Leone Roberti Maggiore U, Paolini B, Diito A, Martinelli F, Lorusso D, Raspagliesi F
- KMID: 2429573
- J Gynecol Oncol.
- 2019 Jan;30(1):e4.
- doi: 10.3802/jgo.2019.30.e4
OBJECTIVE: To examine outcomes of patients having treatments for newly diagnosed advanced stage low-grade serous ovarian cancer (LGSC). METHODS: We conducted a retrospective case series of women affected by advanced stage... -
- CITED
-
- Close
- SHARE
-
- Close
